Peter Gute
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 19
- HIV/AIDS Research and Interventions 5
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- HR Brodt (3 shared papers)Eilke Brigitte Helm (3 shared papers)Bernd S. Kamps (1 shared paper)Bernhard Knupp (1 shared paper)Veronica Miller (5 shared papers)Andrew N. Phillips (4 shared papers)Caroline Anne Sabin (3 shared papers)Schlomo Staszewski (10 shared papers)
- Journals
- AIDS (5 papers)HIV Medicine (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Medical Microbiology and Immunology (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Peter Gute
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 66
- Virology 357
- Infectious Diseases 742
- Emergency Medicine 99
- Hepatology 34
- Nephrology 35
Countries citing papers authored by Peter Gute
This map shows the geographic impact of Peter Gute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gute more than expected).
Fields of papers citing papers by Peter Gute
This network shows the impact of papers produced by Peter Gute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gute. The network helps show where Peter Gute may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Gute, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 347 | |
| 2 | 2000 | 183 | |
| 3 | 1999 | 116 | |
| 4 | 2000 | 70 | |
| 5 | 2008 | 60 | |
| 6 | 2012 | 57 | |
| 7 | 2006 | 34 | |
| 8 | 2013 | 34 | |
| 9 | 2014 | 31 | |
| 10 | 2006 | 30 | |
| 11 | 2007 | 28 | |
| 12 | 2002 | 26 | |
| 13 | 2004 | 26 | |
| 14 | 2004 | 25 | |
| 15 | 1994 | 24 | |
| 16 | 2012 | 21 | |
| 17 | Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users. | 1998 | 20 |
| 18 | 2007 | 18 | |
| 19 | 2008 | 18 | |
| 20 | 2016 | 17 |
About Peter Gute
Peter Gute is a scholar working on Infectious Diseases, Virology, Hepatology, Hematology and Emergency Medicine, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (5 papers), Hepatitis C virus research (5 papers), HIV-related health complications and treatments (2 papers), Platelet Disorders and Treatments (2 papers), Liver Disease Diagnosis and Treatment (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Virology (357 citations), Infectious Diseases (742 citations), Emergency Medicine (99 citations), Hepatology (34 citations) and Nephrology (35 citations). Peter Gute has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include HR Brodt, Eilke Brigitte Helm, Bernd S. Kamps, Bernhard Knupp, Veronica Miller, Andrew N. Phillips, Caroline Anne Sabin, Schlomo Staszewski, Annemarie Berger and Annette Haberl. Their work appears in journals such as AIDS, HIV Medicine, Journal of Antimicrobial Chemotherapy, Medical Microbiology and Immunology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.